Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.556
-0.033 (-5.66%)
Jan 14, 2025, 4:00 PM EST - Market closed
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.64 million as of January 14, 2025. Its market cap has decreased by -28.63% in one year.
Market Cap
2.64M
Enterprise Value
2.36M
1-Year Change
-28.63%
Ranking
Category
Stock Price
0.56
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.64M, a decrease of -94.63%. That is a compound annual growth rate of -29.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 2.60M | -13.33% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.00B |
| UnitedHealth Group | 496.82B |
| Novo Nordisk | 372.55B |
| Johnson & Johnson | 344.55B |
| AbbVie | 309.69B |
| Merck & Co. | 251.56B |
| Thermo Fisher Scientific | 212.48B |
| AstraZeneca | 204.00B |